AstraZeneca CEO considers moving stock to U.S.: report

Pharma giant AstraZeneca, Britain's most valuable public company, is reportedly considering moving its stock to the U.S., The Times reports.

Why it matters: The move would fuel concerns that London's capital markets hub is declining.